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Protein Phosphatase type 2A (PP2A) represents a family of holoenzyme complexes with diverse biological activities.
Specific holoenzyme complexes are thought to be deregulated during oncogenic transformation and oncogene-
induced signaling. Since most studies on the role of this phosphatase family have relied on the use of generic PP2A
inhibitors, the contribution of individual PP2A holoenzyme complexes in PP2A-controlled signaling pathways is largely
unclear. To gain insight into this, we have constructed a set of shRNA vectors targeting the individual PP2A regulatory
subunits for suppression by RNA interference. Here, we identify PR55c and PR55d as inhibitors of c-Jun NH2-terminal
kinase (JNK) activation by UV irradiation. We show that PR55c binds c-SRC and modulates the phosphorylation of
serine 12 of c-SRC, a residue we demonstrate to be required for JNK activation by c-SRC. We also find that the physical
interaction between PR55c and c-SRC is sensitive to UV irradiation. Our data reveal a novel mechanism of c-SRC
regulation whereby in response to stress c-SRC activity is regulated, at least in part, through loss of the interaction with
its inhibitor, PR55c.
Citation: Eichhorn PJA, Creyghton MP, Wilhelmsen K, van Dam H, Bernards R (2007) A RNA interference screen identifies the Protein Phosphatase 2A subunit PR55c as a
stress-sensitive inhibitor of c-SRC. PLoS Genet 3(12): e218. doi:10.1371/journal.pgen.0030218
Introduction
The Src family of nonreceptor tyrosine kinases are integral
players in the mediation of various physiological processes
such as cell motility, adhesion, proliferation, and survival [1].
Members of the Src family share a conserved structure
consisting of four Src homology (SH) domains, a unique
region, and a short negative regulatory tail. The amino
terminal SH4 domain is myristoylated and targets the protein
to the membrane, while the carboxy-terminal SH1 domain
functions as a tyrosine kinase domain [2]. c-SRC activation is
negatively regulated by Carboxy Src Kinase (CSK) or its
homologue CHK through Tyrosine 527 (Tyr
527) phosphor-
ylation [2]. This inhibitory phosphorylation promotes the
assembly of the SH2, SH3, and kinase domains into a closed
conformation [2]. Following stimulation by various stresses
and growth factors c-SRC activation is initiated by dephos-
phorylation of the Tyr
527 residue by the protein-tyrosine
phosphatase PTPa [3] and PTP1B [4]. Alternatively, c-SRC is
activated by the binding of tyrosine-phosphorylated proteins
to the SH2 domain, resulting in destabilization of the
intermolecular interaction between Tyr
527 and the SH2
domain [2]. Subsequently, c-SRC is autophosphorylated at
Tyrosine 416 (Tyr
416), a site within a segment of the kinase
domain termed the activation loop, promoting a conforma-
tional change that allows the kinase to adopt an open active
conﬁrmation [2].
c-SRC is overexpressed or activated in a wide variety of
tumors [5,6]. However, overexpression of c-SRC by itself has
only minor oncogenic potential [7] and mutations in c-SRC in
cancer have only been found sporadically [8]. This led to the
hypothesis that c-SRC has a supportive function in tumori-
genesis rather than a role in the actual transformation
process [9]. Overexpression of v-Src, a constitutively active
form of c-SRC lacking the c-terminal part containing the
inhibitory Tyr
527, is a potent activator of c-Jun NH2-terminal
kinase (JNK), a growth-regulatory enzyme that can control
cell proliferation and cell survival both positively and
negatively, depending on the stimulus and the cellular
context [10,11]. Furthermore, SRC activity is essential for
JNK activation following a number of different stress stimuli,
including UV irradiation [12–14].
Protein Phosphatase 2A (PP2A) is a serine/threonine
phosphatase that can inﬂuence the phosphorylation state of
many signaling enzymes [15,16], and inhibition of this
phosphatase can affect cellular responses such as growth,
differentiation, and apoptosis [15,17]. The holoenzyme gen-
erally exists as a core dimer, consisting of a 36-kDa catalytic
subunit (PP2Ac) and a 65-kDa scaffold subunit (PR65) that
associates with a variety of regulatory subunits. These
regulatory B subunits can modulate the activity of the
PP2Ac/PR65 core unit, thus allowing speciﬁc temporal
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coding for more than 26 (B) regulatory subunits have been
identiﬁed that are subdivided into ﬁve different subfamilies
[17].
The variable PP2A B subunits are targeted by a number of
viral oncogenes, which thereby compete for interaction with
the PR65/PP2Ac core dimer. This suggests that speciﬁc PP2A
holoenzymes play a role in viral propagation and oncogenic
transformation [18,19], which is further supported by the
ﬁnding that general inhibitors of PP2A can cause tumor
growth on the skin and liver of rodents [20–23]. Under-
standing the precise manner in which PP2A is involved in the
regulation of these different signaling cascades and its role
during oncogenic transformation requires the identiﬁcation
of the speciﬁc holoenzymes involved in these processes.
Interpretation of a large amount of data using general PP2A
inhibitors has been limited by the pleiotropic inhibition of all
PP2A holoenzyme complexes by the inhibitors used. Fur-
thermore, ectopic expression of the various B subunits can
lead to competition with other subunits for binding to the
holoenzyme, making it difﬁcult to draw ﬁrm conclusions from
the data [24,25]. Using a gene family knockdown library
targeting all deubiquitinating (DUB) enzymes, we previously
identiﬁed the familial tumor suppressor gene CYLD as a novel
regulator of the NF-jB signaling pathway [26] and USP1 as
the deubiquitinating enzyme of the FANCD2 DNA repair
protein [27]. To study the role of the various PP2A complexes
in speciﬁc pathways we have constructed a library of 61
independent vectors expressing short hairpin RNAs (shRNA)
targeting the PP2A regulatory B subunits for suppression.
Using this knockdown library in a screen for enhancers of
JNK activation following cellular stress, we identiﬁed a
number of PP2A B subunits as novel regulators of JNK
activation, most notably PR55c and PR55d. Furthermore we
demonstrate that the PP2A B subunit PR55c negative
regulates the JNK effector pathway by acting as a stress
sensitive inhibitor of c-SRC activity.
Results
PR55c Is a Modulator of JNK Activity
To identify the speciﬁc PP2A holoenzyme complexes
involved in pathways known to be modulated by PP2A, we
constructed a gene family knockdown library targeting all
putative human PP2A regulatory B subunits for suppression.
We retrieved the cDNA sequences for each of the PP2A
subunit family members from the ENSEMBL database and
designed two to four unique 19-mer sequences for each
transcript for cloning into pSuper and pRetro-Super [26,28].
In total 61 knockdown vectors were generated, which were
then subsequently pooled into 16 sets of two to four vectors
per transcript with each set targeting one of the regulatory B
subunits or a speciﬁc transcript variant (Figure 1A; Table S1).
To validate the pooled knockdown vectors, we tested six
randomly chosen pools of vectors for their ability to
effectively knockdown the target proteins. All pools tested
show a notable reduction in target protein expression levels
(Figure 1B).
Studies using viral proteins that target the regulatory B
subunits of the PP2A holoenzyme complex indicate that JNK
and the proto-oncogene c-Jun can be regulated by PP2A [29].
This suggests that speciﬁc PP2A regulatory B subunits are
involved in PP2A-mediated regulation of the JNK pathway. To
directly assess the putative role of PP2A in JNK regulation we
asked if suppression of one or more PP2A regulatory subunits
by RNA interference could affect JNK activity following UV
irradiation. U2-OS cells were transfected with the different
library pools and then assayed by western blotting for the
efﬁciency of UV induced JNK activation as judged by
threonine-183/tyrosine-185 phosphorylation. Unsurprisingly,
we found that suppression of a number of the B subunits
appeared to enhance the levels of phosphorylated JNK
following UV. Of these, PR55c consistently yielded the
strongest effect and was chosen for further validation (Figure
1C and unpublished data). To evaluate which of the four
individual knockdown vectors in this pool were active against
PR55c, we transfected cells with HA-tagged PR55c and
determined the protein levels of HA-PR55c in lysates of
transfected cells in the presence or absence of the individual
PR55c knockdown vectors. As depicted in Figure 2A, all four
shRNA vectors (A–D) in this pool were able to suppress HA-
PR55c expression levels, whereas no effect was detected on a
cotransfected green ﬂuorescent protein (GFP) (Figure 2A). A
shRNA targeting the mouse-speciﬁc B subunit PR59 was used
as a negative control in all experiments. Vectors A and C were
more efﬁcient in suppressing HA-PR55c protein levels than
vectors B and D (Figure 2A). A ﬁfth knockdown vector (E) was
designed, which like vector C, induced strong suppression of
ectopic PR55c expression (Figure 2A). shRNAs C and E will be
referred from here on as shRNA#1 and shRNA#2, respectively.
To test whether these shRNAs #1 and #2 could inhibit
endogenous PR55c levels we performed quantitative real-
time PCR (QRT-PCR). We found that both shRNAs efﬁciently
suppressed endogenous PR55c mRNA levels (Figure 2B).
Furthermore, inhibition of PR55c with both validated knock-
down vectors could efﬁciently enhance the activation of JNK
by UV irradiation (Figure 2C), arguing against an off-target
effect of the shRNAs. This result underscores the validity of
the screen and suggests that endogenous PR55c is a repressor
of stress-induced JNK activation.
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Author Summary
Protein Phosphatase type 2A (PP2A) represent a family of
holoenzyme complexes involved in wide range of activities such
as growth, differentiation, and cell death. The PP2A holoenzyme
complex is made up of a catalytic, a structural, and one of various
‘‘B’’ subunits. These ‘‘B’’ subunits are thought to provide the
substrate specificity required for PP2A activity. Previous work on
PP2A has mostly been derived by inhibiting the catalytic subunit
through chemical inhibition, as such inhibiting all of the pathways
associated with PP2A. To identify individual ‘‘B’’ subunits involved in
specific cellular processes we have generated a ‘‘B’’ subunit gene
knockdown library, which allows us to inhibit each of the known ‘‘B’’
subunits individually. One of the many pathways regulated by PP2A
is the c-Jun NH2-terminal kinase (JNK) kinase pathway, which,
depending on stimulus, can affect either cell survival or cell
proliferation. Here we report that the ‘‘B’’ subunit PR55c acts as a
negative regulator of JNK activity and cell death. We show that
PR55c influences JNK activity by inhibiting one of its upstream
regulators, the proto-oncogene c-SRC, through dephosphorylation
at one of the key residues on c-SRC, a site we show to be critical for
c-SRC activation following cell stress. Overall our work describes the
novel function of a specific PP2A subunit involved in cell survival
and identifies a novel mechanism of c-SRC regulation.To determine whether the activation of JNK after trans-
fection of PR55c knockdown vectors was a consequence of
the loss of PR55c expression, we performed an add-back
experiment. To do this we restored PR55c levels to the
control situation using a PR55c construct (DPR55c) contain-
ing two noncoding mutations within the region targeted by
knockdown vector #2, rendering it refractory to shRNA-
mediated suppression (Figure 2D). We found that expression
of DPR55c completely abolished the enhanced activation of
UV-induced JNK observed with shRNA vector #2, but not
with shRNA vector #1, which targets a region that was not
mutated in DPR55c (Figure 2E). These results argue that the
effects of the knockdown vectors targeting PR55c for shRNA-
mediated suppression on JNK activation are the result of loss
of PR55c.
To investigate whether the enhanced JNK activation upon
PR55c knockdown is speciﬁc for UV irradiation, we asked
whether other stimuli that lead to the activation of the JNK
pathway might also be enhanced by loss of PR55c. We found
that TNFa, insulin, and osmotic stress-mediated JNK activa-
tion could all be enhanced by suppression of PR55c but not
EGF-mediated JNK activation (Figure 2F). These results
suggest that PR55c is a regulator of the JNK signaling
pathway when activated by diverse stimuli.
It has previously been established that activation of JNK by
UV irradiation can enhance apoptosis in cell culture [30].
Since knockdown of PR55c leads to enhanced JNK activation,
we asked whether knockdown of PR55c could enhance
apoptosis following UV irradiation. UV-induced apoptosis
was indeed signiﬁcantly enhanced in PR55c-depleted cells
(Figure 3A) as determined by measuring the mitochondrial
membrane potential with a ﬂuorescent dye (3,39-dihexyloxa-
carbocyanine iodide, [DiOC6 (3)]). Figure 3B represents three
independent DiOC6 experiments demonstrating the percent-
Figure 1. PP2A Family Screen
(A) Schematic of the PP2A holoenzyme and outline of the B regulatory subunit families.
(B) U2-OS cells were transfected with the indicated pSuper constructs and where available cotransfected with an HA-tagged version of the
corresponding PP2A B subunit. Immunoblot panels show the efficiency of knockdown in six different pools as judged by the ability to knockdown
cotransfected or endogenous protein (GFP is a transfection control).
(C) U2-OS cells were cotransfected with pooled PP2A shRNAs or a control vector. Levels of phosphorylated JNK (a-pJNK) or JNK1 and JNK2 (a-JNK) were
shown in cell lysates for the different samples 60 min after UV treatment of the cells.
doi:10.1371/journal.pgen.0030218.g001
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PR55c Regulates c-SRCage of apoptosis with or without UV in presence of knock-
down vectors targeting PR55c or a control vector. We also
observed an increase in caspase 3 cleavage, a primary
executioner of apoptosis, in lysates of cells exposed to UV
irradiation, when PR55c was suppressed (Figure 3C). Similar
results were obtained with a second shRNA targeting PR55c
(unpublished data).
Inhibition of JNK Activity by PR55c Is Dependent on c-SRC
To investigate whether PR55c regulates the JNK pathway
upstream of JNK we asked if loss of PR55c affected MKK4, the
kinase acting directly upstream JNK [31]. We indeed found
also that MKK4 activity was signiﬁcantly enhanced in cells
with depleted PR55c (Figure 4A). These data suggest that
PR55c does not directly affect JNK phosphorylation levels.
We therefore asked whether the suppression of PR55c had an
effect on the other MAPK pathways, p38 and ERK. Indeed,
western blot analyses indicated that knockdown of PR55c
resulted in increased phosphorylation of both JNK and p38,
but not of ERK following UV irradiation (Figure 4B). Thus
indicating that PR55c acts on a key regulatory protein
required for activation of both JNK and p38. Of note, no
direct interaction was found between PR55c and components
of the MAPK and JNK kinase pathways including the
Figure 2. PR55c Is a Regulator of JNK following UV Irradiation
(A) U2-OS cells expressing pcDNA-HA-PR55c were cotransfected with the pooled knockdown (PR55c
KD) vectors as indicated (A–E) or a control vector.
GFP expression serves as a measure of transfection consistency.
(B) U2-OS cells were cotransfected with PR55c
KD vectors #1 or #2, pcDNA-PR55c serves as a positive control. pSuper vector targeting a mouse PP2A
subunit PR59 served as an shRNA control. mRNA levels relative to the control are shown as evaluated by quantitative real-time PCR.
(C) U2-OS cells were cotransfected with PR55c
KD vectors as indicated (#1 or #2) or control vector. Selected cells were exposed to UV irradiation (100 J/
m
2) and incubated for a further 60 min. Protein samples were analyzed by immunoblotting with antibodies targeting phosphorylated JNK (a-pJNK) or
JNK1 and JNK2 (a-JNK).
(D) U2-OS cells expressing pcDNA-HA-PR55c or pcDNA-HA-PR55c (D) were cotransfected with PR55c
KD vector #2. Protein samples were analyzed by
immunoblotting with antibodies targeting HA.
(E) U2-OS cells expressing pcDNA-HA-PR55c, pcDNA-HA- PR55c(D), or a control vector were cotransfected with PR55c
KD vectors #1 or #2. A pSuper
vector targeting a mouse PP2A subunit PR59 served as an shRNA control. Selected cells were exposed to UV irradiation (100 J/m
2) and incubated for a
further 60 min. Protein samples were analyzed by immunoblotting with antibodies targeting phosphorylated JNK (a- pJNK), total JNK (a-JNK), or
haemoglutinin (a-HA, reprobe).
(F) U2-OS cells expressing PR55c
KD2 vector or a control vector exposed to TNF-a, EGF, NaCl, or insulin for 5 min and incubated for a further 30–60
minutes. pJNK relative to total JNK levels are shown.
doi:10.1371/journal.pgen.0030218.g002
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PR55c Regulates c-SRCpreviously described PP2A interacting proteins JNK, MKK4,
p38, or c-RAF as determined by coimmunoprecipitation
assays (unpublished data) [32–35].
One of the major contributors to the activation of the JNK
pathway is the nonreceptor tyrosine kinase c-SRC [12–14]. It
was previously shown that the polyoma middle t (MT)
antigen, which binds to c-SRC and has been suggested to
compete with the PP2A regulatory B subunit for binding to
the holoenzyme complex [36–38], is also a potent activator of
the JNK signaling cascade [38]. It has recently been described
that of the ubiquitously expressed SRC family members only
c-SRC [39] and LYN [40] play decisive roles in UV-induced
JNK activation. Consistent with this, only c-SRC and Lyn
have putative PKC sites in the N-terminal region. However,
LYN appears to exclusively regulate JNK kinase but not p38
or ERK. Since knockdown of PR55c in our system regulates
not only JNK but also the MAPK p38 (Figure 4B), it would
suggest that c-SRC may be the critical target of PR55c in
negatively regulating the JNK pathway in U2-OS cells
following stress.
To test whether the enhanced activation of JNK after
suppression of PR55c is dependent on c-SRC, we cotrans-
fected a dominant negative version of c-SRC, which has a
lysine 295 to methionine mutation, resulting in a kinase
deﬁcient c-SRC (Src
295M) [41]. UV irradiation-induced JNK
phosphorylation was attenuated in the presence of Src
295M,i n
agreement with the earlier ﬁnding showing that JNK is
activated by both c-SRC independent and c-SRC dependent
pathways [39]. However, the enhancing effect of PR55c
knockdown was completely abolished upon coexpression of
Src
295M (Figure 4C). Likewise inhibition of c-SRC by the
generic Src family inhibitor PP2 also inhibited the enhanced
JNK activity caused by suppression of PR55c (Figure 4D).
Similarly, cotransfection of a hairpin targeting PR55c with an
shRNA targeting c-SRC completely abolished the enhancing
effects of PR55c on JNK activity (Figure 4E).
To further investigate whether PR55c can inﬂuence the
levels of phosphorylated JNK by a non c-SRC family kinase–
associated stimulus, we cotransfected a constitutively active
form of the GTPaseCdc42 (Cdc42
V12), which functions
upstream of MKK4 in the JNK pathway, in the presence or
absence of PR55c. As expected, transfection of Cdc42
V12
Figure 3. PR55c Is a Regulator of Apoptosis following UV Irradiation
(A) U2-OS cells expressing PR55c shRNAs as indicated. Selected cells were exposed to UV irradiation (50 J/m
2) and treated 18 h later with fluorescent
dye measuring mitochondria membrane potential (DiOC6[3)]. FACS scan analysis of treated cells is shown. Right and left peaks reflect living and
apoptotic cells, respectively. Top panel graph represents breakdown of the mitochondrial membrane potential in the absence of UV. Bottom panel
graph represents breakdown of the mitochondrial membrane potential in the presence of UV.
(B) Shown is the percentage of apoptotic cells treated with or without UV. Figure represents three independent experiments.
(C) U2-OS cells were cotransfected with PR55c
KD vector #2 or control vector. Selected cells were exposed to UV irradiation (50 J/m
2) and incubated for a
further 3 h. Protein samples were analyzed by immunoblotting with antibodies targeting phosphorylated cleaved caspase 3. A background band
denotes loading control.
doi:10.1371/journal.pgen.0030218.g003
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PR55c Regulates c-SRCresulted in activation of JNK [42]. However, the knockdown
of PR55c had no signiﬁcant affect on JNK activation, whereas
it did enhance phosphorylation of JNK following exposure to
UV, which served as a control (Figure 4F). Since suppression
of a number of the B subunits appeared to enhance the levels
of phosphorylated JNK following UV (Figure 1C), we wanted
to determine whether the increased levels of phosphorylated
JNK observed with knockdown of the other B subunits are
dependent on c-SRC. As expected knockdown of PR55d
enhanced the activity of JNK following UV irradiation.
Furthermore, like PR55c, the increased JNK activity was
completely attenuated upon cotransfection with kinase dead
Src
295M (Figure 4G). Together these results suggest that PR55c
and PR55d negatively regulate JNK signaling in a c-SRC-
dependent manner. Since PR55c is primarily expressed in
neuronal tissues and PR55d is more ubiquitously expressed, it
may be that PR55c and PR55d mediate the same biochemical
responses to stress in different tissues.
PR55c Interacts with c-SRC
Several studies have suggested a role for PP2A in the
regulation of c-SRC [43–45]. For instance, both polyoma MT
Figure 4. PR55c Regulates JNK Upstream of MKK4 and at the Level or Upstream of c-SRC
(A) pJNK and pMKK4 in relation to the total level of unphosphorylated protein in UV irradiated U2-OS cells followed over time (0–60 min) in the
presence or absence of PR55c
KD2 vector.
(B) U2-OS cells expressing PR55c
KD2 or a control vector were treated with UV and incubated for 60 min. Whole cell extracts were probed with the
indicated antibodies.
(C) PR55c
KD2 vector or control vector were cotransfected as indicated in the presence or absence of c-SRC
295M (dominant negative). Selected cells were
exposed to UV irradiation and whole-cell extracts were analyzed by immunoblotting with antibodies targeting phosphorylated JNK (a-pJNK) or JNK1
and JNK2 (a-JNK).
(D) U2-OS cells were cotransfected with PR55c
KD2 vector or control vector as indicated and incubated with PP2 for 2 h and UV for 1 h. Whole cell
extracts were analyzed by immunoblotting with antibodies targeting phosphorylated JNK (a- pJNK) or JNK1 and JNK2 (a-JNK).
(E) PR55c
KD2 vector or control vector were cotransfected as indicated in the presence or absence of pSuper-c-SRC. Selected cells were exposed to UV
irradiation and whole cell extracts were analyzed by immunoblotting with antibodies targeting phosphorylated JNK (a- pJNK), JNK1 and JNK2 (a-JNK),
or SRC(a- SRC).
(F) PR55c
KD2 vector or control vector were cotransfected as indicated in the presence or absence of CDC42
V12 (dominant active). Selected cells were
exposed to UV irradiation and whole cell extracts were analyzed by immunoblotting with antibodies targeting phosphorylated JNK (a-pJNK) or JNK1 (a-
JNK).
(G) Cells were transfected with either the PP2A pool targeting PR55d vector or control vector and cotransfected as indicated in the presence or absence
of c-SRC
295M (dominant negative). Selected cells were exposed to UV irradiation and whole cell extracts were analyzed by immunoblotting with
antibodies targeting phosphorylated JNK (a-pJNK) or JNK1 and JNK2 (a-JNK).
doi:10.1371/journal.pgen.0030218.g004
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PR55c Regulates c-SRCantigen and adenovirus E4orf4 were previously shown to
interact with both c-SRC and PR55a independently, but the
relevance of these interactions remained elusive [46–48]. To
further address the functional relationship between PR55
and c-SRC, we asked whether PR55c could physically interact
with c-SRC. To investigate this we performed coimmunopre-
cipitation experiments. We found that immunoprecipitation
of c-SRC from lysates of cotransfected cells resulted in
coprecipitation of PR55c (Figure 5A). We also detected this
interaction reciprocally by immunoprecipitating GFP-tagged
PR55c with a GFP antibody and then probing the blotted
precipitate with a c-SRC antibody (Figure 5B). Importantly,
endogenous c-SRC also coimmunoprecipitated with GFP-
PR55c (Figure 5B). Together, these data suggest that PR55c
and c-SRC can form a complex in vivo.
Since PR55c binds to c-SRC we asked if PR55c could form
Figure 5. SRC Coimmunoprecipitates with PR55c
(A) U2-OS cells were transfected as indicated. At 48 h after transfection cells were lysed in ELB and c-SRC was immunoprecipitated using a polyclonal
rabbit c-SRC antibody or normal rabbit serum (nrs). Coimmunoprecipitated GFP-tagged PR55c was detected with a GFP antibody. Whole cell lysates
(WCL) were probed using c-SRC or GFP antibodies to detect transfected protein.
(B) Reverse immunoprecipitation as in (A) GFP was immunoprecipitated using a mouse GFP antibody or normal mouse serum (nms).
Coimmunoprecipitated c-SRC was detected with a c-SRC specific antibody. The blot was subsequently reprobed with a GFP antibody to visualize
the amount of immunoprecipitated GFP-tagged PR55c protein. Whole cell lysates (WCL) were probed using c-SRC or GFP antibodies to detect
transfected protein. (*) represents the light chain antibody.
(C) U2-OS cells were transfected as indicated. Lysates were immunoprecipitated using a FLAG antibody. The blot was probed with a LYN specific
antibody and then subsequently reprobed with a FLAG antibody to visualize the amount of immunoprecipitated FLAG-tagged PR55c protein.
(D) U2-OS cells were transfected as indicated. Lysates were immunoprecipitated using a FLAG antibody. The blot was probed with a FYN specific
antibody and then subsequently reprobed with a FLAG antibody to visualize the amount of immunoprecipitated FLAG-tagged PR55c protein.
(E) U2-OS were transfected as indicated. c-SRC was immunoprecipitated using a c-SRC antibody. Coimmunoprecipitated HA-tagged PR55c or HA-
tagged PR72 was detected with a HA-specific antibody. The blot was subsequently reprobed with a c-SRC antibody to visualize the amount of
immunoprecipitated c-SRC protein. Whole cell lysates (WCL) were probed using c-SRC or HA antibodies to detect transfected protein.
(F) Immune precipitation of FLAG-tagged c-SRC and the PP2Ac/PR65 core dimer in HEK 293 cells in the presence (right) or absence (left) of GFP-PR55c.
The left panel shows 10% of the total lysate.
(G) U2-OS cells were transfected as indicated. At 48 h after transfection cells were treated with UV (100 J/ m
2) and incubated for a further 10, 30, 60, and
120 min, respectively. Equal amounts of cell lysate (500 lg) were immunoprecipitated with a- c-SRC antibody. Coimmunoprecipitated GFP-tagged
PR55c was detected with a GFP specific antibody. The blot was subsequently reprobed with a c-SRC antibody to visualize the amount of
immunoprecipitated c-SRC protein. Whole cell lysates (WCL) were probed using c-SRC or GFP antibodies to detect transfected protein.
doi:10.1371/journal.pgen.0030218.g005
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PR55c Regulates c-SRCphysical complexes with other SRC family members. We
cotransfected FLAG-PR55c with either the c-SRC family
kinases LYN or FYN. We found that LYN and FYN do not
share the ability of c-SRC to interact with PR55c in
coimmunoprecipitation assays (Figure 5C and 5D)
To test if the PR55c/c-SRC interaction was speciﬁc for the
B subunit PR55c we cotransfected c-SRC with PR55c or the
PP2A B
’’ subunit PR72. As shown in Figure 5E, c-SRC
physically associated with PR55c but failed to coimmunopre-
cipitate with PR72.
Moreover, the speciﬁc binding of c-SRC to the B subunit
PR55c suggests that PR55c is able to recruit the holoenzyme
complex to c-SRC. We therefore asked if PR55c could
mediate binding of the PR65/PP2Ac core dimer to c-SRC.
We transfected HEK293 cells with constructs expressing
FLAG-SRC, HA-PR65, and HA-PP2Ac in the presence or
absence of GFP- PR55c and performed coimmunoprecipita-
tion assays for FLAG-SRC. We found that c-SRC formed a
complex with the PP2A holoenzyme exclusively in the
presence of PR55c, indicating that PR55c is required as
bridging factor between c-SRC and the PR65/PP2Ac core
dimer (Figure 5F). These observations demonstrate that
PR55c speciﬁcally interacts with c-SRC and mediates the
recruitment of the PR65/PP2Ac core dimer to c-SRC.
The physical interaction between PR55c and c-SRC
suggests a role as a modulator of c-SRC activity. Since c-
SRC activity is increased following UV irradiation, we asked
whether UV irradiation could affect the interaction between
PR55c and c-SRC. We followed the interaction between
PR55c and c-SRC after UV irradiation by performing
immunoprecipitation experiments. We found that the inter-
action between PR55c and c-SRC was gradually lost over time
(Figure 5G) demonstrating that the interaction between c-
SRC and PR55c is sensitive to UV irradiation.
PR55c Modulates c-SRC Activation
Since PR55c appears to regulate JNK activation at the level
of c-SRC, we examined the role of PR55c on c-SRC- activated
transcription of a JNK responsive luciferase reporter. We
found that suppression of PR55c enhanced the ability of c-
SRC to activate this reporter (Figure 6A). Conversely, over-
expression of PR55c represses the ability of c-SRC to activate
this reporter (Figure 6B). Consistent with these results,
western blot analyses demonstrate that overexpression of c-
SRC causes an increase in JNK phosphorylation after UV
(Figure 6C). Moreover, when we cotransfected short hairpins
targeting PR55c in the presence of c-SRC, we observed that
suppression PR55c enhanced the levels of phosphorylated
JNK compared to c-SRC alone (Figure 6D). Consistent with
this, ectopic expression of PR55c inhibited the synergistic
activation of JNK mediated by c-SRC and UV (Figure 6E).
These results demonstrate that PR55c is able to inﬂuence c-
SRC-mediated signaling to the JNK pathway.
To assess whether PR55c directly modulates c-SRC kinase
activity, we evaluated c-SRC Tyr
416 phosphorylation, a hall-
mark of its activity [2], by western blot analyses. We found
that knockdown of PR55c could further enhance c-SRC
Tyr
416 phosphorylation following stimulation by UV irradi-
ation (Figure 6F). In contrast overexpression of PR55c could
reduce c-SRC Tyr
416 phosphorylation following stimulation
by UV irradiation (Figure 6G). Together, these results suggest
that PR55c is an inhibitor of c-SRC activity.
PR55c Mediates Dephosphorylation of Serine 12 on c-SRC
Several studies have indicated that pretreatment with the
PP2A inhibitor okadaic acid (O.A.) induces the phosphor-
ylation of the PKC phosphorylation site, Ser12 on c-SRC,
while simultaneously stimulating c-SRC kinase activity
[45,49]. To further investigate if PR55c alters the phosphor-
ylation status of SRC
Ser12, we stimulated U2-OS cells with UV
irradiation in the presence of [
32P] orthophosphate and
performed a 2D tryptic phospho-peptide analysis of phos-
phorylated c-SRC. Indeed, comparisons with tryptic phos-
phopeptide maps indicate that overexpression of PR55c
decreased the levels of the phosphorylated Ser12 peptide
while okadaic acid slightly increased the phosphorylation
levels of the Ser12 peptide, when compared to control
samples (Figure 7A–7E). Of note peptide maps showed similar
patterns to those performed by Moyers et al. [47]. Similar
results were observed when the cells were treated with
phorbal 12-myristate 13-acetate (PMA) and Forskolin, potent
activators of PKC and PKA, respectively (unpublished data).
From these data we conclude that treatment with either UV
or PMA induces the phosphorylation of the PKC site Ser12 on
c-SRC and that this speciﬁc phosphorylation event is
signiﬁcantly diminished in cells overexpressing PR55c.O f
note, no direct interaction was observed between PR55c and
PKCd, the kinase that directly phosphorylates Ser12 of c-SRC,
as determined by coimmunoprecipitation assays (unpub-
lished data).
Since phosphorylation of a speciﬁc target sequence has
been suggested to be one of the requirements for the
targeting of the B regulatory subunit and the subsequent
recruitment of the PP2A holoenzyme to the substrate, we
wanted to address whether recruitment of PR55c to c-SRC is
dependent upon the phosphorylation status of residue Ser12.
To answer this question we generated a gain-of-function
(SRC
S12D) and a loss-of-function (SRC
S12A) mutant of this
phospho-site. To test if phosphorylation of Ser12 was
required for the binding of PR55c we cotransfected HA-
PR55c with either: FLAG-SRC, FLAG- SRC
S12D, or FLAG-
SRC
S12A in the presence or absence of UV irradiation and
performed coimmunoprecipitation assays. As shown in
Figure 7F, mutation of serine 12 to an alanine decreased
the association with PR55c compared to wild-type c-SRC,
while the association of PR55c with SRC
S12D signiﬁcantly
increased. However, the association of PR55c with either
wild-type c-SRC or the mutant forms of SRC
Ser12 were
completely abolished following UV irradiation. Together
these results suggest that phosphorylation of Ser12 is one of
the factors determining PR55c afﬁnity towards c-SRC and
demonstrates that the interaction between PR55c and c-SRC
is sensitive to UV irradiation regardless of the presence of a
phospho-moiety on Ser12.
To determine whether the effects of PR55c on SRC
Ser12
phosphorylation were the cause of PR55c-mediated c-SRC
regulation, we examined the role of SRC
Ser12 on a JNK-
responsive luciferase reporter. We found that overexpression
of the SRC
S12A mutant signiﬁcantly inhibited c-SRC’s ability
to activate a JNK-responsive luciferase promoter (Figure 7G).
Conversely, overexpression of SRC
S12D enhanced c-SRC’s
ability to activate the JNK-responsive luciferase promoter
(Figure 7G).
Since SRC
S12D and SRC
S12A signiﬁcantly enhanced and
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luciferase promoter respectively, we wanted to determine
whether phosphorylation of this site affects c-SRC kinase
activity. Kinase activity was assayed by monitoring the levels
of phosphorylated enolase as an exogenous substrate. As
shown above (Figure 6F and 6G), exposure to UV irradiation
increases the activation of c-SRC compared to nonstimulated
cells (Figure 7H). However, the c-SRC kinase activity was
severely crippled in cells expressing SRC
S12A. Furthermore, c-
Src kinase activity was signiﬁcantly enhanced in SRC
S12D cells
compared to controls in unstimulated cells (Figure 7H).
Similar results were detected when measuring the autophos-
phorylation of c-SRC at Tyr
416 (Figure 7I). Taken together
these results demonstrate that phosphorylation of Ser12 on c-
Src is one of the requirements for full activation of the
protein following stress.
Inhibition of JNK Activity by PR55c Is Dependent on c-SRC
Ser12
To determine if the observed effect on JNK activity by
PR55c following UV stimulation is dependent on Ser12, we
cotransfected hairpins targeting PR55c with wild-type c-SRC
or the SRC
S12A mutant and measured the levels of phos-
phorylated JNK by western blotting following UV irradiation.
As expected knockdown of PR55c intensiﬁed the effect on
JNK phosphorylation compared to c-SRC alone. However, the
enhancing effect of PR55c knockdown on JNK phosphor-
ylation was completely attenuated upon coexpression on the
SRC
S12A mutant (Figure 8A). In agreement with this result,
cotransfection of SRC
S12D interfered with PR55c’s ability to
inhibit JNK phosphorylation following exposure to UV
(Figure 8B). Our data collectively demonstrate that modu-
Figure 6. PR55c Regulates c-SRC-Induced JNK Activation
(A) U2-OS cells expressing a 53 AP1-luciferase construct (pGL2), pSUPER-PR55c, or pcDNA-c-SRC as indicated. Luciferase counts are shown relative to
the control.
(B) U2-OS cells expressing a 53AP1-luciferase construct (pGL2), pcDNA-HA-PR55c, or pcDNA-c-SRC as indicated. Luciferase counts are shown relative to
the control.
(C) U2-OS cells were transfected with FLAG-SRC or a control vector and treated with UV. Whole cell extracts were probed with the indicated antibodies.
(D) U2-OS cells were cotransfected with FLAG-SRC, pSUPER-PR55c, or a control vector and treated with UV. Whole cell extracts were probed with the
indicated antibodies.
(E) U2-OS cells were cotransfected with FLAG-SRC, pcDNA-HA-PR55c, or a empty vector and treated with UV. Whole cell extracts were probed with the
indicated antibodies.
(F) U2-OS cells expressing pcDNA-HA-hairpins targeting PR55c or a control vector, and pcDNA-c-SRC were serum starved for 48 h and treated with UV
irradiation for 30 min. Cells were lysed in ELB and equivalent amounts of protein were immunoprecipitated with a c-SRC specific antibody. c-SRC
phosphorylation was detected with an antibody targeting phosphorylated tyrosine 416 (a-pTyr
416) and immunoprecipitated c-SRC was detected with
an a-c-SRC antibody.
(G) U2-OS cells expressing pcDNA-HA-PR55c or a control vector and pcDNA-c-SRC were serum starved for 48 h and treated with UV irradiation for 30
min. Cells were lysed in ELB and equivalent amounts of protein were immunoprecipitated with a c-SRC specific antibody. c-SRC phosphorylation was
detected with an antibody targeting phosphorylated tyrosine 416 (a-pTyr
416) and immunoprecipitated c-SRC was detected with an a-c-SRC antibody.
doi:10.1371/journal.pgen.0030218.g006
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S12 phosphorylation by PR55c is critical for
PR55c’s effects on JNK activation.
We next asked whether SRC
S12A could abrogate the
enhanced apoptosis observed with knockdown of PR55c.
We cotransfected hairpins targeting PR55c with either
SRC
S12A or wild-type c-SRC and quantiﬁed apoptosis using
DiOC6 staining following exposure to UV irradiation. In line
with results above (Figure 3A), knockdown of PR55c
increased UV-induced apoptosis in the presence of wild-type
c-SRC. However, coexpression of SRC
S12A completely cur-
tailed the enhancing effect of PR55c suppression (Figure 8C).
In contrast, coexpression of PR55c and c-SRC repressed UV-
induced apoptosis compared to c-SRC alone, while these
effects were completely abolished when PR55c was coex-
pressed with SRC
S12D (Figure 8D). Taken together, these
results demonstrate that the regulation of c-SRC by PR55c
and its subsequent effects on cell survival are mediated
through regulation of Ser12 phosphorylation on c-SRC.
Discussion
It has previously been proposed that the stress response to
environmental stimuli mediated by the JNK pathway is
regulated by PP2A protein phosphatase activity [33,50,51],
although the way in which this pathway is regulated and the
speciﬁc PP2A holoenzyme responsible for this regulation
have not been identiﬁed. Via an RNAi-mediated gene family–
knockdown screen of regulatory PP2A B subunits, we now
Figure 7. PR55c Regulates Serine 12 Phosphorylation on c-SRC
(A) Phosphotryptic pattern of U2-OS cells expressing c-SRC from untreated cells.
(B–E) Phosphopeptides of c-SRC following treatment with UV (100 J/ m
2) for 30 min in the presence of 2 mCi [
32P]orthophosphate (B), c-SRC plus PR55c
(C), c-SRC pretreated for 1 h with 1 lM okadaic acid (D), and Ser12A mutant (E). Phosphorylated c-SRC was immunoprecipitated, and samples were
subjected to phosphopeptide mapping as described under ‘‘Materials and Methods’’.
(F) U2-OS cells were transfected as indicated. 48 h after transfection cells were treated with UV (100 J/m
2) and incubated for a further 120 min. Cells
were lysed in ELB, and equal amounts of cell lysate (500 lg) were immunoprecipitated using a FLAG antibody (Sigma). Coimmunoprecipitated HA-
tagged PR55c was detected with an HA antibody. Whole cell lysates (WCL) were probed using FLAG or HA antibodies to detect transfected protein.
(G) U2-OS cells expressing a 53AP1-luciferase construct (pGL2), Flag-SRC, Flag- SRC
S12A, Flag- SRC
S12D, or control vector as indicated. Luciferase counts
are shown relative to the control.
(H) U2-OS cells were transfected as indicated. At 48 h after transfection cells were washed twice in PBS and incubated for a further 72 h in medium
without FCS. Cells were treated with UV (200 J/m
2) and incubated for a further 30 min in the same medium. Equal amounts of cell lysate (500 lg) were
immunoprecipitated with a-Flag antibody and in vitro kinase assays were performed using enolase as a substrate.
(I) U2-OS cells were transfected as indicated. At 48 h after transfection cells were washed twice in PBS and incubated for a further 72 h in medium
without FCS. Cells were treated with UV (200 J/m
2) and incubated for a further 30 min in the same medium. Equal amounts of cell lysate (500 lg) were
immunoprecipitated with a-Flag antibody and analyzed by western blot for either tyrosine phosphorylation at residue 416 (top panel) or FLAG (bottom
panel).
doi:10.1371/journal.pgen.0030218.g007
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induced JNK activation. We ﬁnd that PR55c regulates the JNK
pathway through negative regulation of c-SRC kinase activity.
Importantly, we identify here c-SRC serine 12 as a critical
residue for the regulation of the c-SRC kinase activity during
stress signaling. We show that PR55c physically interacts with
c-SRC and has a higher afﬁnity for c-SRC when it is
phosphorylated on serine 12. Since the interaction of the
PP2A holoenzyme complex with c-SRC is dependent on
PR55c, this would suggest a transient interaction between
PR55c-containing PP2A holoenzyme and c-SRC, which is
reduced as soon as serine 12 dephosphorylation has occurred.
Previous work has indicated that PP2A might play a role in
the regulation of c-SRC activity, since treatment of cells with
okadaic acid, a chemical inhibitor of PP2A [22], resulted in
enhanced c-SRC activity [45], and PP2A can inactivate c-SRC
in vitro [43]. Interestingly, polyoma MT is able to compete
with the PP2A B regulatory subunit for interaction with the
PR65/PP2Ac core dimer [38], and overexpression of polyoma
MT is able to activate c-Jun kinase by virtue of its interaction
with PP2A [29]. Furthermore, polyoma MT was also found to
interact with c-SRC [36] leading to its activation [37].
Moreover, it was reported that adenovirus E4orf4 can
interact with both c-SRC and PR55a independently and that
the interaction with c-SRC is required for E4orf4 to induce
apoptosis [46,52]. Overexpression of E4orf4 phenocopies loss
of PR55 in yeast [53], allowing the possibility that inhibition
of PR55a is a prerequisite for E4orf4-induced apoptosis in
mammalian cells. Our data identifying PR55c as a negative
regulator of c-SRC are in agreement with these studies and
could suggest that these viral proteins may function to
displace PR55c from c-SRC.
It has previously been reported that JNK is activated by
both c-SRC independent and c-SRC dependent pathways [39].
This present study conﬁrms and extends these results by
demonstrating that the inhibition of SRC by PR55c does not
completely inhibit JNK activation but rather results in an
overall decrease, similar to the effects observed with a kinase
dead mutant of c-SRC. In contrast, knockdown of PR55c
increases SRC kinase activity following UV resulting in
enhanced levels of phosphorylated JNK. These results suggest
that modulation of one of the upstream activator pathways
may result in a prolonged and ampliﬁed JNK effect.
It has previously been shown that the majority of c-SRC is
present in the perinuclear region where it was found to be
inactive as judged by Tyr 416 phosphorylation [54]. c-SRC was
Figure 8. Inhibition of JNK Activity by PR55c Is Dependent upon Ser12 of c-SRC
(A) PR55c
KD2 vector or control vector were cotransfected as indicated in the presence of FLAG-SRC or FLAG- SRC
S12A. Selected cells were exposed to UV
irradiation and whole cell extracts were analyzed by immunoblotting with antibodies targeting phosphorylated JNK (a-pJNK), JNK1 and JNK2 (a-JNK), or
FLAG (a-FLAG).
(B) GFP-PR55c vector or control vector were cotransfected as indicated in the presence of FLAG-SRC or FLAG- SRC
S12D. Selected cells were exposed to
UV irradiation and whole cell extracts were analyzed by immunoblotting with antibodies targeting phosphorylated JNK (a- pJNK), JNK1 and JNK2 (a-
JNK), FLAG (a-FLAG), or GFP (a-GFP).
(C) U2-OS cells coexpressing PR55c shRNAs and FLAG-SRC or FLAG- SRC
S12A as indicated. Selected cells were exposed to UV irradiation (50 J/m
2) and
treated 18 h later with fluorescent dye measuring mitochondria membrane potential (DiOC6[3]). Figure represents three independent experiments.
(D) U2-OS cells expressing PR55c and FLAG-SRC or FLAG- SRC
S12D as indicated. Selected cells were exposed to UV irradiation (50 J/m
2) and treated 18 h
later with fluorescent dye measuring mitochondria membrane potential (DiOC6[3]). Figure represents three independent experiments.
doi:10.1371/journal.pgen.0030218.g008
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increasing activity and moved to the membrane in response
to various stimuli where it was fully active [54]. Similarly we
found PR55c to be primarily expressed in the perinuclear
region indicating that PR55c may colocalise with c-SRC
(unpublished data). These data suggest that PR55c may
interact with c-SRC within the perinuclear region inhibiting
the induction of c-SRC by PKC by limiting the phosphor-
ylation status of Ser12. Since PR55c did not decrease the
overall levels of other phosphorylation sites within the unique
region of c-SRC primarily SER17, phosphorylation of which
has been shown to be involved in SRC dependent ERK
signaling [55], it suggests that the selective response of c-SRC
following PKC phosphorylation at Ser12 may reﬂect the
restricted activation of the JNK downstream effector pathway
through either, phosphorylation dependent changes in
subcellular localization, as suggested by Liebenhoff et al.
who demonstrated that cytoskeletal association of pp60c-src
is dependent on phosphorylation of pp60c-src at Ser12 by
PKC [56] or by regulation of the binding of proteins that may
function to regulate the activity of c-SRC towards JNK.
One of the intriguing ﬁndings of this study is that upon
treatment of cells with UV irradiation the interaction
between c-SRC and PR55c is lost. We propose a model in
which we suggest that in response to stress c-SRC is activated
in part by losing the interaction with its inhibitor allowing c-
SRC to be localized to the plasma membrane and subsequent
activation of the downstream JNK effector pathways (Figure
9). Similarly, it was described for PR55a that its interaction
with the PP2Ac/PR65 dimer is sensitive to gamma irradiation
[57]. Further work will be required to reveal the mechanism
of UV-induced dissociation of the c-SRC/PR55c in response
to stress.
Materials and Methods
Plasmids and antibodies. pcDNA3- FLAG-SRC, pEGFP-SRC, pMT-
SRC, pMT-SRC(527), pMT-SRC(295), pcDNA-LYN, and pcDNA-FYN
(Table S2) were kindly provided by P. Stork, G. Superti-Furga, W.
Molenaar, and J. Borst. All other Flag-, GFP-, and HA-coding
constructs were generated using pcDNA (Invitrogen). Detailed
cloning information will be provided upon request. PP2A knockdown
library vectors were generated by annealing the individual oligonu-
cleotide primer pairs and cloning them into pSuper as described in
[58].The bacterial colonies of each B subunit were then pooled and
used for plasmid preparation. The extra shRNA (E) that gave the most
efﬁcient knockdown against PR55c as described in Figure 2A was
generated by ligating synthetic oligos (Sigma) against the target
sequence 59-CATGGAGGCAAGACCCATAG-39 into pSuper. The c-
SRC knockdown sequence was obtained from Gonzalez et al. and
cloned into pSuper [59]. Antibodies anti-p-JNK, anti-p-MKK-4, anti-
p-Src(416), and cleaved caspase-3 were from Cell Signaling; anti-SRC,
anti-JNK (C-17), anti-MKK4, HA (Y11), anti-GFP, and anti-FYN were
purchased from Santa Cruz Biotechnology Inc. The anti-LYN
antibody was a kind gift from J. Borst.
Cell culture, transient transfections, and Luciferase assays. All cells
were cultured in Dulbecco’s modiﬁed Eagle medium (DMEM)
supplemented with 10% fetal calf serum, D-Glutamate, and Pen-
icillin/Streptomycin. U2-OS cells were divided in 10-cm dishes 1 d
prior to transfection. Subconﬂuent cells were transfected using the
calcium phosphate transfection method [60]. Cells were incubated
overnight, washed in PBS, and puromycin selected (1.5 lg/ml) for 48
h. When required cells were serum starved for 48 h prior to
stimulation. The cells were not allowed to reach conﬂuency. For the
screen and subsequent knockdown experiments, U2-OS cells were
cotransfected with 20 lg of pooled PP2A shRNAs and 1 lg of pBabe-
puro. After 72 h, selected cells were trypsinized and 53105 cells were
plated out in a 10-cm dish. After incubating overnight cells were
exposed to UV irradiation (100 J/m
2) and incubated for a further 60
min in the same medium. The following agents were used to stimulate
cells: 50 ng/ml EGF (Upstate), 10 ng/ml TNF (Sigma), 10 ng/ml Insulin
(Sigma), 500 mM NACL, or UVC (254 nm, 100 J/m
2). Luciferase assays
were performed using the Dual luciferase system (Promega). AP1
luciferase vector (300 ng) was transfected in the presence of CMV-c-
SRC (0.5 lg) or a control vector and CMV-Renilla (0.25 lg). For loss of
function, 2.5 lg of pSuper vector [58] was cotransfected, and
luciferase counts were measured 72 h post-transfection using a TD-
20/20 Luminocounter (Promega). For gain-of-function assays, 0.5 lg
of CMV construct or control vector (empty CMV) was cotransfected,
and luciferase counts were measured 48 h post-transfection.
Apoptosis assay. For detection of apoptotic cells, selected cells
were incubated for 72 h, trypsinized, and incubated for another 10–
12 h in new media. The cells were washed twice in PBS and incubated
for 18–24 h following UV treatment (50 J/m
2), trypsinized, washed
once with PBS, and resuspended for 10–15 minutes in 250 ll PBS
containing 40 nM DiOC6 (3). After incubation the cells were analyzed
by FACS analysis.
Western blotting and coimmunoprecipitation. Cells were lysed in
solubilizing buffer (50 mM Tris [pH 8.0], 150 mM NaCl, 1 % NP-40,
0.5% deoxycholic acid, 0.1% SDS, 1 mM Sodium Vanadate, 1 mM
pyrophosphate, 50 mM sodium ﬂuoride, 100 mM b-glycerol phos-
phate), supplemented with protease inhibitors (Complete; Roche).
Whole cell extracts were then separated on 7%–12% SDS-Page gels
and transferred to polyvinylidene diﬂuoride membranes (Millipore).
Membranes were blocked with bovine serum albumin and probed
with speciﬁc antibodies. Blots were then incubated with an HRP-
linked second antibody and resolved with chemiluminescence
(Pierce). For coimmunoprecipitations, cells were lysed in ELB (0.25
M NaCl, 0.1%NP-40, 50 mM HEPES [pH 7.3]) supplemented with
protease inhibitors. Lysates were then incubated for 2 h with 2 lgo f
the indicated antibodies conjugated to protein A or protein G
sepharose beads, washed three times in ELB buffer, and separated on
SDS-PAGE gels. When appropriate cell lystates were immunopreci-
pitated with ANTI-FLAG M2 Afﬁnity Gel (Sigma).
2D tryptic phospho-peptide analysis and phospho-labeling. For
tryptic phosphopeptide analysis U2-OS cells were cotransfected with
4 lg Flag-Src or 4lg or Flag-Src (12A) and 20 lg PR55c or control
vector. Cells were phospho-starved for 45 min and 2 mCi of [
32 P]
orthophosphate was then added to the cells and incubated an
additional 3 h. PMA at a ﬁnal concentration of 200 nM was added for
30 min at 37 8C or the cells were treated with UV irradiation (100 J/
m
2) and incubated for a further 30 min at 37 8C. c-SRC was
immunoprecipitated with Flag antibody (Sigma) as described above.
The entire sample was loaded onto an SDS-PAGE gel, run, and then
dried. The ﬁlm was then exposed for 3 h at room temperature. The
radioactive bands were then isolated, proteins eluted, digested with
trypsin, and phosphopeptide mapping was performed as described
Figure 9. Model for the Regulation of c-SRC-Induced JNK Activation following UV Signaling by PP2A Complexes
doi:10.1371/journal.pgen.0030218.g009
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PR55c Regulates c-SRCpreviously [61,62]. For phospholabeling analysis HEK 293 cells were
cotransfected with 4 lg Flag-PR55c,1 0lg HA-PR65, and 10 lg HA-
PP2Ac. Cells were phospho-starved for 45 min, UV stimulated as
above, and then 2 mCi of [
32 P] orthophosphate was added to the cells
and incubated for a further 2 h in the same medium. c-SRC was
immunoprecipitated with Flag antibody (Sigma) and an HA antibody
(Y11, Santa Cruz) as described above. The entire sample was loaded
onto an SDS-PAGE gel, run, and then dried.
Supporting Information
Table S1. Gene Names and Primer Sequences
Found at doi:10.1371/journal.pgen.0030218.st001 (114 KB DOC).
Table S2. Gene Names and GenBank Numbers
Found at doi:10.1371/journal.pgen.0030218.st002 (26 KB DOC).
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